Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors
Michio Sakai(Yao Tokushukai General Hospital), Akira Shirahata(Kitakyushu City Hospital Organization), Motoaki Chin(Nihon University), Masataka Ishimura(Kyushu University Hospital), Sho Harano(KM Biologics (Japan)), Kagehiro Amano(Tokyo Medical University Hospital), Hideyuki Takedani(University of Tokyo Hospital), Hiroyuki Ishida(Kyoto City Hospital), Hiroyoshi Watanabe(Tokushima University), Masashi Taki(St. Marianna University School of Medicine), Keiji Nogami(Nara Medical University), Masahiro Migita(Japanese Red Cross Kumamoto Hospital), Kazuo Sakashita(Nagano Children's Hospital)
Cited by 5
Related Papers
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19
|Leukemia|2006|126
Factors associated with granulocyte colony‐stimulating factor‐induced peripheral blood stem cell yield in healthy donors
|Vox Sanguinis|2005|118
Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking
|Transfusion|2004|114
The first selective linear codimerization of terminal acetylenes and 1,3-dienes catalyzed by dihydridotetrakis(trialkylphosphine)ruthenium complexes
|The Journal of Organic Chemistry|1985|89
Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues Bearing a Hydroxyalkoxy Group at the 2.BETA.-Position.
|Chemical and Pharmaceutical Bulletin|1993|82